Skip to main content

Table 4 IC50 values of N. sativa essential oil (F0) and its nanoemulsions (F1 and F2) against HepG2 and Huh-7 hepatocellular carcinoma cells at different incubation time

From: Cytotoxic, apoptotic, and genetic evaluations of Nigella sativa essential oil nanoemulsion against human hepatocellular carcinoma cell lines

Incubation time

IC50 and fold change

HepG2

Huh-7

RDa

F0

F1

F2

RD

F0

F1

F2

24 h

IC50 (µg/ml)

100.0

98.39

65.27

55.74

100.0

90.44

52.38

35.5

Fold change (a)

–

1.01

1.53

1.79

–

1.10

1.90

2.81

Fold change (b)

–

1.00

1.5

1.76

–

1.00

1.72

2.54

48 h

IC50 (µg/ml)

97.65

73.97

60.96

54.34

95.94

76.00

51.78

35.33

Fold change (a)

–

1.00

1.21

1.36

–

1.00

1.47

2.15

Fold change (b)

–

1.32

1.60

1.80

–

1.26

1.85

2.72

72 h

IC50 (µg/ml)

92.61

66.23

49.26

45.10

89.21

45.10

41.14

25.00

Fold change (a)

–

1.00

1.34

1.47

–

1.47

1.57

2.59

Fold change (b)

–

1.40

1.88

2.05

–

1.38

2.17

3.57

  1. Fold change (a): (IC50 RD/IC50 F0, F1 or F2)
  2. Fold change (b): (IC50 F0/IC50 F1 or F2)
  3. RD reference drug (Doxorubicin)